|ORPHAN DRUGS AND RARE
DISEASES EUROPE 2017
PLAZA BERLIN, POTSDAMER PLATZ, BERLN, GERMANY
15th - 16th MAY 2017 | WORKSHOPS: 17th MAY 2017
hope that you will be able to join us this May for the 6th annual Orphan Drugs and Rare Diseases
Europe conference, taking place
in Europe's largest pharmaceutical market, Berlin.
currently possessing one of the toughest pricing mechanisms and
policies in Europe, this year's Orphan Drugs conference is the perfect opportunity to unite and establish an
interactive platform exploring how payers, pharma, biotech and patient
organisations are preparing to participate and leverage the rapidly
growing orphan drugs and rare diseases market.
the 22 novel drugs approved by the FDA, the FDA approved 9 products
with orphan designation, in line with the industry’s recent focus on
rare disease..." *
TODAY USING CODE SMI112J
TO SAVE AN
Our panel of pharmaceutical professionals
will take the stage to discuss 'The
sustainability of orphan drugs'. Which will shed light on
just how crucial the continued research of
drugs and rare diseases truly is. Must hear topics of
discussion will include:
- Economic tools that
improve access to orphan drugs
- Sustainability of
orphan drug reimbursement
- How can we ensure the
ongoing sustainability of orphan drugs?
- Is there a correlation
between sustainability and the cost-effectiveness and affordability?
||Carina Schey, Health
Global Market Access Solutions
Partner, RBV Capital
like-minded industry experts in topical discussions and presentations on
the most recent developments within the inherently niche orphan drugs
The complete speaker list is available here.
forget to check out our CPD certified post conference workshops Wednesday 17th May 2017 here.
A: The impact of Brexit
on the Orphan Drug Market
08.30 - 12.30
B: Is the Party over,
13.30 - 17.30
REMINDER: THE £100 EARLY BIRD DISCOUNT WILL EXPIRE SOON!REGISTER ONLINE TODAY TO SECURE YOUR SPACE.
offer sponsorship, exhibition, advertising and branding packages,
uniquely tailored to complement your company’s marketing strategy.
Prime networking opportunities exist to entertain, enhance and expand
your client base within the context of an independent discussion
specific to your industry. Should you wish to join the increasing
number of companies benefiting from sponsoring our conferences please
Alia Malick | +44
(0) 20 7827 6168 | email: email@example.com
delegate enquiries please contact:
Adolis Miniauskas |+44 (0)
207 827 6744 | email: firstname.lastname@example.org
look forward to meeting you,
Orphan Drugs and Rare Diseases Europe 2017 Team